Journal
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING
Volume 37, Issue 2, Pages 146-157Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1552-6909.2008.00232.x
Keywords
microarray; gene expression; complex disorder; genetic susceptibility; preeclampsia
Categories
Funding
- NCATS NIH HHS [UL1 TR000005] Funding Source: Medline
Ask authors/readers for more resources
Preeclampsia is a life-threatening perinatal complication with unknown etiology. Microarray technology has characterized global gene expression in complex disorders such as preeclampsia. Nursing research and future practice may incorporate findings from microarray analyses to identify susceptibility to and prevent disease, to design and monitor personalized therapies. This overview of microarray technology, with emphasis on how it can inform genomics of preeclampsia, may provide concepts to improve future maternal-neonatal nursing care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available